First-in-Humans Evaluation of Safety and Dosimetry of<sup>64</sup>Cu-LLP2A for PET Imaging-Reference-Cited by-同舟云学术

First-in-Humans Evaluation of Safety and Dosimetry of⁶⁴Cu-LLP2A for PET Imaging

Published:2022-08-25 Issue:2 Volume:64 Page:320-328
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Laforest Richard,Ghai Anchal,Fraum Tyler J.,Oyama Reiko,Frye Jennifer,Kaemmerer Helen,Gaehle Greg,Voller Tom,Mpoy Cedric,Rogers Buck E.,Fiala Mark,Shoghi Kooresh I.,Achilefu Samuel,Rettig Michael,Vij Ravi,DiPersio John F.,Schwarz Sally,Shokeen Monica,Dehdashti Farrokh

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference39 articles.

1. RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice

2. FDG-PET imaging in hematological malignancies;Valls;Blood Rev.,2016

3. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention

4. Genomic instability in multiple myeloma;Alagpulinsa;Trends Cancer.,2020

5. The genetic architecture of multiple myeloma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptide PET Imaging: A Review of Recent Developments and a Look at the Future of Radiometal-Labeled Peptides in Medicine;Chemical & Biomedical Imaging;2024-08-22

2. Dosimetry of [⁶⁴Cu]FBP8: a fibrin-binding PET probe;2024-06-28

3. Albumin-Binding Lutetium-177-Labeled LLP2A Derivatives as Theranostics for Melanoma;Molecular Pharmaceutics;2024-04-29

4. Molecular Imaging of Fibrosis in Benign Diseases: An Overview of the State of the Art;Pharmaceuticals;2024-02-26

5. Current and Future PET Imaging for Multiple Myeloma;Life;2023-08-07